Cetrelimab (Anti-PDCD1 / PD-1 / CD279)
Cetrelimab (Anti-PDCD1 / PD-1 / CD279) is a humanized monoclonal antibody targeting programmed cell death 1 (PD-1). It inhibits tumor growth in vivo. MW :145.04 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A3029 |
Sku # | A3029-1mg*25 |
Pricing | 1mg*25, $2970.00 |